GT Biopharma
Price & Volume
Stats
See moreOpen | $6.75 |
Previous Close | $6.68 |
Day Range | $6.67-$7.05 |
52W Range | $4.91-$28.75 |
Market Cap | $12M |
Shares Short | 259,425 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$147.50 |
News
See moreYahoo Finance • 5 months ago
GT Biopharma Records Q1 Loss Of $2 Mln; Advances GTB-3650 In Phase 1 Trial For Leukemia
Yahoo Finance • 5 months ago
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
Yahoo Finance • 7 months ago
GT Biopharma Reports Full Year 2025 Financial Results
Yahoo Finance • 10 months ago
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
About
CEO | Mr. Michael Martin Breen L.L.B. |
CFO | Mr. Alan Louis Urban CPA |
Address | 315 Montgomery Street, San Francisco, CA, United States, 94104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1 |